文献速递妇科

地诺孕素对比GnRH激动剂在子宫内膜异位症术后的疗效:系统综述与Meta分析

Efficacy of Dienogest Versus GnRH Agonists After Endometriosis Surgery: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Minim Invasive Gynecol · 2025-11-22

该系统综述与Meta分析比较了子宫内膜异位症腹腔镜术后使用地诺孕素(DNG)与促性腺激素释放激素(GnRH)激动剂在症状控制、不良反应及病灶复发方面的疗效。共纳入6项随机对照试验,结果显示两组术后3个月和6个月盆腔痛及性交痛VAS评分无显著差异,6个月影像学病灶复发无统计学差异;DNG与阴道出血风险升高相关,GnRH激动剂与潮热更常相关。

要点

  • 术后3个月和6个月盆腔痛及性交痛VAS评分两组无显著差异。
  • DNG组阴道出血风险显著高于GnRH激动剂组(RR 4.16)。
  • GnRH激动剂组潮热发生率显著高于DNG组(RR 0.33)。

核心结论

  • DNG与GnRH激动剂在腹腔镜子宫内膜异位症术后疼痛管理和病灶复发方面疗效相当。
  • 由于纳入研究存在高偏倚风险,这些发现应谨慎解读。
  • DNG似乎更常与阴道出血相关,而GnRH激动剂更常与潮热相关。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE和Cochrane Central数据库2000年1月至2025年5月的文献。
  • 纳入比较术后使用DNG或GnRH激动剂的随机对照试验,共6项研究符合纳入标准。
  • 纳入对象为18至45岁因子宫内膜异位症行腹腔镜手术切除的女性。
  • 采用随机效应模型计算合并风险比(RR)和均数差及其95%置信区间。

主要发现

  • 术后3个月和6个月盆腔痛及性交痛视觉模拟量表(VAS)评分两组无显著差异。
  • DNG组潮热发生率显著低于GnRH激动剂组(RR 0.33,95%CI 0.11-0.98)。
  • 其他不良事件两组间无显著差异。
  • 术后6个月影像学评估的病灶复发两组无统计学差异(RR 0.62,95%CI 0.23-1.70)。

局限性

  • 纳入研究存在高偏倚风险,应谨慎解读这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review and meta-analysis compared the efficacy of dienogest (DNG) and gonadotropin-releasing hormone (GnRH) agonists in the management of endometriosis-related symptoms following surgical intervention, their related adverse effects, and lesion recurrence. DATA SOURCES: A comprehensive literature search was conducted across PubMed, EMBASE, and Cochrane Central databases, encompassing publications from January 2000 to May 2025. METHODS OF STUDY SELECTION: Randomized controlled trials comparing postoperative medical treatment with either DNG or a GnRH agonist were systematically reviewed for inclusion. Eligible participants were women aged 18 to 45 years who underwent laparoscopic surgery for endometriosis excision. TABULATION, INTEGRATION, AND RESULTS: Data from included studies were described using mean ± standard deviation for normally distributed variables and median and range for non-normally distributed variables. Statistical analyses utilized a random-effects model to compute pooled risk ratios (RR) and mean differences with 95% confidence intervals. Primary outcomes assessed included pelvic pain, dyspareunia, dysmenorrhea, chronic pelvic pain, lesion recurrence by imaging, and incidence of adverse events. Six studies met the inclusion criteria. No significant differences were observed between the groups concerning pelvic pain and dyspareunia Visual Analog Scale (VAS) scores at 3 and 6 months post-surgery. DNG was associated with a significantly higher risk of vaginal bleeding (RR 4.16, CI 1,98-8.75), and a lower incidence of hot flushes (RR 0.33, CI 0.11-0.98). No other adverse events demonstrated significant inter-group differences. Lesion recurrence at 6 months assessed by postoperative imaging was not statistically different between groups (RR 0.62, CI 0.23-1.70). CONCLUSION: This meta-analysis shows that DNG and GnRH agonists demonstrate comparable efficacy in postoperative pain management and lesion recurrence after laparoscopic endometriosis excision. These findings, however, should be interpreted with caution due to the high risk of bias of the included studies. DNG appears to be more frequently associated with vaginal bleeding, whereas GnRH agonists are more often linked to hot flushes.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Servidoni ACP, Martin GC, Gaio GS, et al. Efficacy of Dienogest Versus GnRH Agonists After Endometriosis Surgery: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol. 2025. PMID: 41285345. doi:10.1016/j.jmig.2025.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。